KWILP
ARKG icon

Kiwi Wealth Investments Limited Partnership’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,344
Closed -$1.15M – 221
2020
Q4 		$1.15M Buy
+12,344
New +$983K 0.07% 212

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's ARKG Position: Q1 2021 in Review

Kiwi Wealth Investments Limited Partnership sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 12,344 shares — an estimated $1.15M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in ARKG in Q4 2020 and held it in 1 quarter. The position peaked at $1.15M in Q4 2020. 506 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

  • Kiwi Wealth Investments Limited Partnership reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 12,344 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $1.15M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's ARK Genomic Revolution ETF position peaked at $1.15M in Q4 2020.
  • 506 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q1 2021, filed 18 May 2021.